Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by Stereoelectroencephalography

A. Astner-Rohracher, G. Zimmermann, T. Avigdor, C. Abdallah, N. Barot, M. Brázdil, I. Doležalová, J. Gotman, JA. Hall, K. Ikeda, P. Kahane, G. Kalss, V. Kokkinos, M. Leitinger, I. Mindruta, L. Minotti, MM. Mizera, I. Oane, M. Richardson, SU....

. 2022 ; 79 (1) : 70-79. [pub] 20220101

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011529

Importance: Stereoelectroencephalography (SEEG) has become the criterion standard in case of inconclusive noninvasive presurgical epilepsy workup. However, up to 40% of patients are subsequently not offered surgery because the seizure-onset zone is less focal than expected or cannot be identified. Objective: To predict focality of the seizure-onset zone in SEEG, the 5-point 5-SENSE score was developed and validated. Design, Setting, and Participants: This was a monocentric cohort study for score development followed by multicenter validation with patient selection intervals between February 2002 to October 2018 and May 2002 to December 2019. The minimum follow-up period was 1 year. Patients with drug-resistant epilepsy undergoing SEEG at the Montreal Neurological Institute were analyzed to identify a focal seizure-onset zone. Selection criteria were 2 or more seizures in electroencephalography and availability of complete neuropsychological and neuroimaging data sets. For validation, patients from 9 epilepsy centers meeting these criteria were included. Analysis took place between May and July 2021. Main Outcomes and Measures: Based on SEEG, patients were grouped as focal and nonfocal seizure-onset zone. Demographic, clinical, electroencephalography, neuroimaging, and neuropsychology data were analyzed, and a multiple logistic regression model for developing a score to predict SEEG focality was created and validated in an independent sample. Results: A total of 128 patients (57 women [44.5%]; median [range] age, 31 [13-58] years) were analyzed for score development and 207 patients (97 women [46.9%]; median [range] age, 32 [16-70] years) were analyzed for validation. The score comprised the following 5 predictive variables: focal lesion on structural magnetic resonance imaging, absence of bilateral independent spikes in scalp electroencephalography, localizing neuropsychological deficit, strongly localizing semiology, and regional ictal scalp electroencephalography onset. The 5-SENSE score had an optimal mean (SD) probability cutoff for identifying a focal seizure-onset zone of 37.6 (3.5). Area under the curve, specificity, and sensitivity were 0.83, 76.3% (95% CI, 66.7-85.8), and 83.3% (95% CI, 72.30-94.1), respectively. Validation showed 76.0% (95% CI, 67.5-84.0) specificity and 52.3% (95% CI, 43.0-61.5) sensitivity. Conclusions and Relevance: High specificity in score development and validation confirms that the 5-SENSE score predicts patients where SEEG is unlikely to identify a focal seizure-onset zone. It is a simple and useful tool for assisting clinicians to reduce unnecessary invasive diagnostic burden on patients and overutilization of limited health care resources.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011529
003      
CZ-PrNML
005      
20220506131030.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1001/jamaneurol.2021.4405 $2 doi
035    __
$a (PubMed)34870697
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Astner-Rohracher, Alexandra $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada $u Department of Neurology, Christian Doppler University Hospital, Centre for Cognitive Neuroscience Paracelsus Medical University Hospital Salzburg, affiliated Member of the Epicare Reference Network, Salzburg, Austria
245    10
$a Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by Stereoelectroencephalography / $c A. Astner-Rohracher, G. Zimmermann, T. Avigdor, C. Abdallah, N. Barot, M. Brázdil, I. Doležalová, J. Gotman, JA. Hall, K. Ikeda, P. Kahane, G. Kalss, V. Kokkinos, M. Leitinger, I. Mindruta, L. Minotti, MM. Mizera, I. Oane, M. Richardson, SU. Schuele, E. Trinka, A. Urban, B. Whatley, F. Dubeau, B. Frauscher
520    9_
$a Importance: Stereoelectroencephalography (SEEG) has become the criterion standard in case of inconclusive noninvasive presurgical epilepsy workup. However, up to 40% of patients are subsequently not offered surgery because the seizure-onset zone is less focal than expected or cannot be identified. Objective: To predict focality of the seizure-onset zone in SEEG, the 5-point 5-SENSE score was developed and validated. Design, Setting, and Participants: This was a monocentric cohort study for score development followed by multicenter validation with patient selection intervals between February 2002 to October 2018 and May 2002 to December 2019. The minimum follow-up period was 1 year. Patients with drug-resistant epilepsy undergoing SEEG at the Montreal Neurological Institute were analyzed to identify a focal seizure-onset zone. Selection criteria were 2 or more seizures in electroencephalography and availability of complete neuropsychological and neuroimaging data sets. For validation, patients from 9 epilepsy centers meeting these criteria were included. Analysis took place between May and July 2021. Main Outcomes and Measures: Based on SEEG, patients were grouped as focal and nonfocal seizure-onset zone. Demographic, clinical, electroencephalography, neuroimaging, and neuropsychology data were analyzed, and a multiple logistic regression model for developing a score to predict SEEG focality was created and validated in an independent sample. Results: A total of 128 patients (57 women [44.5%]; median [range] age, 31 [13-58] years) were analyzed for score development and 207 patients (97 women [46.9%]; median [range] age, 32 [16-70] years) were analyzed for validation. The score comprised the following 5 predictive variables: focal lesion on structural magnetic resonance imaging, absence of bilateral independent spikes in scalp electroencephalography, localizing neuropsychological deficit, strongly localizing semiology, and regional ictal scalp electroencephalography onset. The 5-SENSE score had an optimal mean (SD) probability cutoff for identifying a focal seizure-onset zone of 37.6 (3.5). Area under the curve, specificity, and sensitivity were 0.83, 76.3% (95% CI, 66.7-85.8), and 83.3% (95% CI, 72.30-94.1), respectively. Validation showed 76.0% (95% CI, 67.5-84.0) specificity and 52.3% (95% CI, 43.0-61.5) sensitivity. Conclusions and Relevance: High specificity in score development and validation confirms that the 5-SENSE score predicts patients where SEEG is unlikely to identify a focal seizure-onset zone. It is a simple and useful tool for assisting clinicians to reduce unnecessary invasive diagnostic burden on patients and overutilization of limited health care resources.
650    _2
$a kohortové studie $7 D015331
650    12
$a elektroencefalografie $7 D004569
650    _2
$a epilepsie $x diagnóza $x chirurgie $7 D004827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a předoperační péče $7 D011300
650    _2
$a záchvaty $x diagnóza $x chirurgie $7 D012640
650    _2
$a průzkumy a dotazníky $x normy $7 D011795
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Zimmermann, Georg $u Team Biostatistics and Big Medical Data, IDA Lab Salzburg, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Avigdor, Tamir $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
700    1_
$a Abdallah, Chifaou $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
700    1_
$a Barot, Nirav $u Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania
700    1_
$a Brázdil, Milan $u Department of Neurology, Faculty of Medicine, Masaryk University and St Ann's University Hospital, Brno, Czech Republic
700    1_
$a Doležalová, Irena $u Department of Neurology, Faculty of Medicine, Masaryk University and St Ann's University Hospital, Brno, Czech Republic
700    1_
$a Gotman, Jean $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
700    1_
$a Hall, Jeffery Alan $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
700    1_
$a Ikeda, Kirsten $u Dalhousie University and Hospital, Division of Neurology, Halifax, Nova Scotia, Canada
700    1_
$a Kahane, Philippe $u CHU Grenoble-Alpes, Université Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France
700    1_
$a Kalss, Gudrun $u Department of Neurology, Christian Doppler University Hospital, Centre for Cognitive Neuroscience Paracelsus Medical University Hospital Salzburg, affiliated Member of the Epicare Reference Network, Salzburg, Austria
700    1_
$a Kokkinos, Vasileios $u Department of Neurosurgery, Massachusetts General Hospital, Boston
700    1_
$a Leitinger, Markus $u Department of Neurology, Christian Doppler University Hospital, Centre for Cognitive Neuroscience Paracelsus Medical University Hospital Salzburg, affiliated Member of the Epicare Reference Network, Salzburg, Austria
700    1_
$a Mindruta, Ioana $u Neurology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
700    1_
$a Minotti, Lorella $u CHU Grenoble-Alpes, Université Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France
700    1_
$a Mizera, Mary Margaret $u Department of Neurology, Northwestern University, Chicago, Illinois
700    1_
$a Oane, Irina $u Neurology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
700    1_
$a Richardson, Mark $u Department of Neurosurgery, Massachusetts General Hospital, Boston
700    1_
$a Schuele, Stephan U $u Department of Neurology, Northwestern University, Chicago, Illinois
700    1_
$a Trinka, Eugen $u Department of Neurology, Christian Doppler University Hospital, Centre for Cognitive Neuroscience Paracelsus Medical University Hospital Salzburg, affiliated Member of the Epicare Reference Network, Salzburg, Austria $u Neuroscience Institute, Christian Doppler University Hospital, Centre for Cognitive Neuroscience Paracelsus Medical University Hospital Salzburg, Salzburg, Austria $u Karl Landsteiner Institute for Neurorehabilitation and Space Neurology, Salzburg, Austria $u Department of Public Health, Health Services Research and Health Technology Assessment, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria
700    1_
$a Urban, Alexandra $u Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania
700    1_
$a Whatley, Benjamin $u Dalhousie University and Hospital, Division of Neurology, Halifax, Nova Scotia, Canada
700    1_
$a Dubeau, François $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
700    1_
$a Frauscher, Birgit $u Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
773    0_
$w MED00180402 $t JAMA neurology $x 2168-6157 $g Roč. 79, č. 1 (2022), s. 70-79
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34870697 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131022 $b ABA008
999    __
$a ok $b bmc $g 1789238 $s 1162727
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 79 $c 1 $d 70-79 $e 20220101 $i 2168-6157 $m JAMA Neurology $n JAMA Neurol $x MED00180402
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace